(Q30444156)

21 June 2017

The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis (English)

1 reference

21 June 2017

0 references

1 reference

1 reference

3

Elizabeth M Brunt

1 reference

21 June 2017

Stephen H Caldwell

1

1 reference

21 June 2017

James T Patrie

2

1 reference

21 June 2017

Jan A Redick

4

1 reference

21 June 2017

Christine A Davis

5

1 reference

21 June 2017

Sang H Park

6

1 reference

21 June 2017

Brent A Neuschwander-Tetri

7

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

21 June 2017

1 reference

21 June 2017

46

1 reference

21 June 2017

4

1 reference

21 June 2017

1101-1107

1 reference

The content of adenosine polyphosphates in fatty livers

21 June 2017

1 reference

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

21 January 2018

1 reference

NASH: a mitochondrial disease

21 January 2018

1 reference

7 January 2021

Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study

1 reference

7 January 2021

Uncoupling protein-2 and non-alcoholic fatty liver disease

1 reference

7 January 2021

Optical diffraction studies of crystalline structures in electron micrographs. II. Crystalline inclusions in mitochondria of human hepatocytes

1 reference

7 January 2021

Mitochondrial abnormalities in non-alcoholic steatohepatitis

1 reference

7 January 2021

Significance of megamitochondria in alcoholic liver disease

1 reference

7 January 2021

Mitochondria in nonalcoholic fatty liver disease

1 reference

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

7 January 2021

The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis

1 reference

7 January 2021

The organization, promoter analysis, and expression of the human PPARgamma gene

1 reference

7 January 2021

Peroxisome proliferator-activated receptor-γ agonists in atherosclerosis: current evidence and future directions

1 reference

7 January 2021

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

7 January 2021

Thiazolidinediones for nonalcoholic steatohepatitis--promising but not ready for prime time

1 reference

7 January 2021

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

1 reference

7 January 2021

Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity

1 reference

7 January 2021

Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone

1 reference

7 January 2021

Mechanisms of the depot specificity of peroxisome proliferator-activated receptor gamma action on adipose tissue metabolism

1 reference

7 January 2021

Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression

1 reference

7 January 2021

Enlarged hepatocytes in NAFLD examined with osmium fixation: does microsteatosis underlie cellular ballooning in NASH?

1 reference

7 January 2021

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

1 reference

7 January 2021

Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver

1 reference

7 January 2021

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

7 January 2021

Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?

1 reference

7 January 2021

Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients

1 reference

7 January 2021

Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial

1 reference

7 January 2021

Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro

1 reference

7 January 2021

Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo

1 reference

7 January 2021

Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues

1 reference

7 January 2021

Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo

1 reference

7 January 2021

Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement

1 reference

7 January 2021

Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion

1 reference

7 January 2021

PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21813

1 reference

21 June 2017

1 reference